putative relationship genetic haemochromatosis piz alpha NUMBER antitrypsin deficiency studied using monoclonal antibody piz variant NUMBER consecutive patients genetic haemochromatosis seen karolinska hospital huddinge university hospital stockholm NUMBER year period NUMBER patients haemochromatosis piz homozygotes odds ratio NUMBER confidence interval NUMBER NUMBER p NUMBER prevalence heterozygous piz phenotype similar general population p NUMBER ascertainment period liver biopsy performed NUMBER NUMBER patients NUMBER NUMBER NUMBER piz homozygotes cirrhosis compared NUMBER piz variant p NUMBER homozygous heterozygous alpha NUMBER antitrypsin deficient patients developed hepatocellular carcinoma compared NUMBER NUMBER NUMBER gene carriers p NUMBER homozygous phenotype developed severe emphysema hla typing performed NUMBER patients NUMBER NUMBER manifested antigens known linked haemochromatosis significant differences piz gene carriers mean age onset disease sex distribution hla type piz heterozygotes plasma alpha NUMBER antitrypsin concentrations normal range group mean lower carriers p NUMBER data suggest presence piz allele alpha1 antitrypsin deficiency double dose associated genetic haemochromatosis contribute earlier onset cirrhosis patients does increase risk hepatocellular carcinoma non carriers non piz non carriers non piz NUMBER NUMBER